Open AccessEpigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2
Author(s) -
Tomokazu Ohishi,
Takayuki Hishiki,
Mirza S. Baig,
Sajjan Rajpoot,
Uzma Saqib,
Tomohiko Takasaki,
Yukihiko Hara
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0271112
Subject(s) - coronavirus , angiotensin converting enzyme 2 , epigallocatechin gallate , receptor , severe acute respiratory syndrome , pharmacology , biology , biochemistry , medicine , disease , infectious disease (medical specialty) , antioxidant , covid-19 , polyphenol
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom